Vasoactive factors and tubulointerstitial injury

Kidney and Blood Pressure Research

Volumn 22, Issue 1-2, 1999, Pages 62-70

  Wolf, Gunter ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Angiotensin II; Endothelins; Natriuretic peptides; Progression of chronic renal failure; Transforming growth factor beta

Indexed keywords

ANGIOTENSIN; CHEMOKINE; CYTOKINE; ENDOTHELIN; GROWTH FACTOR; ICOSANOID; NATRIURETIC FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE AGENT;

ARCHITECTURE; ATROPHY; BLOOD VESSEL TONE; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FIBROBLAST; FIBROSIS; HUMAN; HYPERTROPHY; INFLAMMATORY CELL; KIDNEY BLOOD FLOW; KIDNEY INTERSTITIUM; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE DAMAGE; MORPHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; EICOSANOIDS; ENDOTHELINS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; NATRIURETIC AGENTS; RECEPTORS, ADRENERGIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032978265     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025910     Document Type: Review

References (89)

1. Addis T, Oliver J: The Renal Lesion in Bright's Disease. New York, Hoeber, 1931.
2. Risdon RA, Sloper JC, de Wardener HE: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 1968;1:363-366.
3. Bohle A, Mackensen-Haen S, Gise H, Grund KE, Wehrmann M, Batz C, Bogenschutz O, Schmitt H, Nagy J, Mueller C, Mueller GA: The consequences of tubulointerstitial changes for renal function in glomerulopathies. Pathol Res Pract 1990;186:135-144.
4. Cameron JS: Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr Nephrol 1992;6:292-303.
5. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
6. Strutz F, Neilson EG: Transdifferentiation: A new angle on renal fibrosis. Exp Nephrol 1996;4:267-270.
7. Wolf G: Vasoactive substances as regulators of renal growth. Exp Nephrol 1993;1:141-151.
8. Anderson S, Rennke HG, Brenner BW: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
9. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I: Cause of variable therapeutic efficiency of angiotensin-converting enzyme inhibitor on glomerular lesions. Kidney Int 1991; 40:195-202.
10. Klahr S, Morrissey JJ: Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int 1997;52(suppl 63):S111-S114.
11. Wolf G: Regulating factors of renal tubular hypertrophy. Clin Invest 1993;71:867-870.
12. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993;3: 1531-1540.
13. Wolf G, Neilson EG: Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int 1993;43(suppl 39):S100-S107.
14. Wolf G, Ziyadeh FN: Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 1997;7:448-454.
15. Wolf G: Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: Beyond haemodynamics. Nephrol Dial Transplant 1998;13:1131-1142.
16. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: Emphasis on non-hemodynamic mechanisms. Am J Kidney Dis 1997;29:153-163.
17. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 1990;259: F768-F777.
18. 1 receptor. Nephrol Dial Transplant 1993;8: 128-133.
19. Chatterjee PK, Weerackody RP, Mistry SK, Hawsworth GM, McLay JS: Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells. Kidney Int 1997;51:699-705.
20. Harris RC: Regulation of S6 kinase activity in renal proximal tubule. Am J Physiol 1992;263: F127-F134.
21. Wolf G, Killen PD, Neilson EG: Intracellular signaling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Regul 1991;2:219-227.
22. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A: Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998;31: 342-348.
23. Wolf G, Kuncio GS, Sun MJ, Neilson EG: Expression of homoebox genes in a proximal tubular cell line derived from adult mice. Kidney Int 1991;39:1027-1033.
24. Kip1. Kidney Int 1996;50:2112-2119.
25. Kip1 and induction of hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int 1998;54:1923-1933.
26. 1 cells Nephrol Dial Transplant 1995;10: 1305-1312.
27. Wolf G, Mueller E, Stahl RAK, Ziaydeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993;92:1366-1372.
28. Wolf G, Ziyadeh FN, Zahner G, Stahl RAK: Angioetnsin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: Attenuation after stable transfection with the c-mas oncogene. Kindey Int 1995;48:1818-1827.
29. Wolf G, Ziyadeh FN, Stahl RAK: Angiotensin II (A II) stimulates transcription of transforming growtn factor beta receptor type II (TGF-β RII) in proximal tubular (MCT) cells (abstract). J Am Soc Nephrol 1998;9:409.
30. Wolf G, Zahner G, Schroeder R, Stahl RAK: Transforming growth factor beta mediates the angiotens n II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol Dial Transplant 1996; 11:263-269.
31. Wolf G, Kalluri R, Ziyadeh FN, Stahl RAK: Angiotensin II (A II) stimulates α3 chain of type IV collagen in cultured proximal tubular (MCT) cells (abstract). J Am Soc Nephrol 1997;8:410.
32. Wolf G, Ziyadeh FN, Helmchen U, Zahner G, Schroeder R, Stahl RAK: ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop. Am J Physiol 1995;268:F940-F947.
33. Heeger P, Wolf G, Meyers C, Sun MJ, O'Farrel SC, Krensky AM, Neilson EG: Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int 1992;41:220-225.
34. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RAK: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: Role of the angiotensin type 2 receptor. J Clin Invest 1997; 100:1047-1058.
35. Wolf G, Mentzel S, Assmann KJM: Aminopeptidase A: A key enzyme in the intrarenal degradation of angiotensin II. Exp Nephrol 1997;5:364-369.
36. Wolf G, Thaiss F, Mueller E, Disser M, Pooth R, Zahner G, Stahl RAK: Glomerular mRNA expression of angiotensinase A after renal ablation. Exp Nephrol 1995;3:240-248.
37. Scherberich JE, Wolf G, Albers C, Nowack A, Stuckhardt C, Schoeppe W: Glomerular and tubular membrane antigens reflecting cellular adaptation in human renal failure. Kidney Int 1989;36(suppl 27):S38-S51.
38. Czekalski S, Chansel D, Vandermeersch S, Ronco P, Ardaillou R: Evidence for angiotensin IV receptors in human collecting duct cells. Kidney Int 1996;50:1125-1131.
39. Dulin N, Madhun ZT, Chnag CH, Berti-Mattera L, Dickens D, Douglas JG: Angiotensin IV receptors and signaling in opossum kidney cells. Am J Physiol 1995;269:F644-F652.
40. Kerins DM, Hao Q, Vaughan DE: Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 1995;96:2515-2520.
41. Ruiz-Ortega M, Egido J: Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997;52:1497-1510.
42. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 1992;19:464-474.
43. Wolf G: Link between angiotensin II and TGF-β in the kidney. Miner Electrolyte Metab 1998;24:174-180.
44. Harris RC, Martinez-Maldonado M: Angiotensin II-mediated renal injury. Miner Electrolyte Metab 1995;21:328-335.
45. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-945.
46. The GISEN group: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-1863.
47. Ravid M, Brosh D, Levi Z, Bar-dayan Y, Ravid D, Rachmani R: Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. Ann Intern Med 1998;128:982-988.
48. Inonue A, Yanagisawa M, Kimura S, Kayasu Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-2867.
49. Kohan DE: Endothelins in the normal and diseased kidney. Am J Kidney Dis 1997;29:2-26.
50. Ujiie K, Terada Y, Nonoguchi H, Shinohara M, Tomita K, Marumo F: Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments. J Clin Invest 1992;90: 1043-1048.
51. Schnermann JB, Zhu XL, Shu X, Yang T, Huang YG, Kretzler M, Briggs JP: Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-β. Endocrinology 1996;137:5000-5008.
52. Kohan DE: Endothelins: Renal tubular synthesis and action. Clin Exp Pharmacol Physiol 1996;23:337-344.
53. + exchange activity by endothelin in opossum kidney cells. Eur J Physiol 1995;430:137-144.
54. Ong ACM, Jowett TP, Firth JD, Burton S, Kitamura M, Fine LG: Human tubular-derived endothelin in the paracrine regulation of renal interstitial fibroblast function (abstract). Exp Nephrol 1994;2:134.
55. Hocher B, Thöne-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD, Theuring F: Endothelin-1 transgenic mice develop glomerulosclerosis. interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 1997;99:1380-1389.
56. Bruzzi I, Corna D, Zoja C, Orisio S, Shiffrin EL, Cavallotti D, Remuzzi G, Benigni A: Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am J Pathol 1997;151:1241-1247.
57. Zoja C, Liu XH, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A: Angiotensin II bloackade limits tubular protein overreabsorption and the consequent upregulation of endothelin I gene in experimental membranous nephropathy. Exp Nephrol 1998;6:121-131.
58. Bakris GL, Re RN: Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cvells. Am J Physiol 1993;264: F937-F942.
59. Wolf G, Ziyadeh FN, Zahner G, Stahl RAK: Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension 1996;27:897-905.
60. Kon V, Hunley TE, Fogo A: Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Transplantation 1995;60:89-95.
61. Brown M, Chou SY, Porush JG: Endothelins and kidney diseases. Nephron 1996;72:375-382.
62. Wolf G, Thaiss F, Stahl RAK: Cyclosporine stimulates expression of transforming growth factor-β in renal cells. Transplantation 1995; 60:237-241.
63. Lüscher TF, Wenzel RR: Endothelin in renal disease: Role of endothelin antagonists. Nephrol Dial Transplant 1995;10:162-166.
64. Weinmann EJ, Sansom SC, Knight TF, Senekjian HO: Alpha and beta adrenergic agonists stimulate water absorption in the rat proximal tubule. J Membr Biol 1982;69:107-111.
65. 1 cells. J Am Soc Nephrol 1994;4:1995-2002.
66. Wolf G, Helmchen U, Stahl RAK: Isoproterenol stimulates tubular DNA replication in mice. Nephrol Dial Transplant 1996;11:2288-2292.
67. Stahl RAK: Prostaglandins and leukotrienes; in Neilson EG, Couser WG (eds): Immunologie Renal Diseases. Philadelphia. Lippincott-Raven, 1997; pp 469-487.
68. Stahl RAK, Thaiss F: Eicosanoids: biosynthesis and function in the glomerulus. Renal Physiol 1987;10:1-13.
69. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, Smithies O: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995;83:473-482.
70. Klotmann PE, Smith SR, Volpp BD: Thromboxane synthesis inhibition improves function of hydronephrotic rat kidneys. Am J Physiol 1986;250:F282-F287.
71. Pelayo JC, Shanley PF: Glomerular and tubular adaptive responses to acute nephron loss in the rat. Effect of prostaglandin synthesis inhibition. J Clin Invest 1990;85:1761-1769.
72. Stahl RAK, Kudelka S, Helmchen U: High protein intake stimulates glomerular prostaglandin formation in remnant kidneys. Am J Physiol 1987;252:F1083-F1094.
73. Zoja C, Perico N, Corna D, Benigni A, Gabanelli M, Morigni M, Bertanin T, Remuzzi G: Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remant kidney. J Am Soc Nephrol 1990;1:799-807.
74. Purkerson ML, Joist JH, Yates J, Valdes A, Morriosn A, Klahr S: Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 1985;82:193-197.
75. Fujihara CK, Malheiros DM, Donato JL, Poli A, De Nucci G, Zatz R: Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney. Am J Physiol 1998;274:F573-F579.
76. 2 on mRNA expression and secretion of collagens I, III, and IV and fibronectin in cultured rat mesangial cells. J Am Soc Nephrol 1994;4:1778-1785.
77. 2 stimulates expression of matrix metalloproteinase in cultured rat mesangial cells. Kidney Int 1997;51:1116-1123.
78. Schneider A, Thaiss F, Rau HP, Wolf G, Zahner G, Jocks T, Helmchen U, Stahl RAK: Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: Possible role of TGF-β. Kidney Int 1996;50:190-199.
79. Studer RK, Craven PA, DeRubertis FR: Thromboxane stimulation of mesangial cell fibronectin synthesis is signalled by protein kinase C and modulated by cGMP. Kidney Int 1994;46:1074-1082.
80. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998;339:321-328.
81. Appel RG: Growth inhibitory activity of atrial natriuretic factor in rat glomerular mesangial cells. FEBS Lett 1988;238:135-138.
82. Wolf G, Thaiss F, Schoeppe W, Stahl RAK: Angiotensin II-induced proliferation of cultured murine mesangial cells: inhibitory role of atrial natriuretic peptide. J Am Soc Nephrol 1992;3:1270-1278.
83. Wolf G, Ziyadeh FN, Stahl RAK: Atrial natriuretic peptide stimulates the expression of transforming growth factor-β in cultured murine mesangial cells: Relationship to suppression of proliferation. J Am Soc Nephrol 1995;6:224-233.
84. Canaan-Kühl S, Ostendorf T, Zander K, Koch KM, Floege J: C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int 1998;53: 1143-1151.
85. Mistry SK, Chatterjee PK, Weerackody RP, Hawksworth GM, Knott RM, McLay JS: Evidence for atrial natriuretic factor induced natriuretic peptide receptor subtype switching in rat proximal tubular cells during culture. Exp Nephrol 1998;6:104-111.
86. Garcid-Ocana A, Penaranda C, Esbrit P: Comparison of antiproliferative effects of atrial natriuretic peptdie and transforming growth factor β on rabbit kidney proximal tubule cells. Life Sci 1996;58:251-258.
87. Logan JL, Michael UF: Atrial natriuretic peptide suppresses compensatory renal growth in rats. J Am Soc Nephrol 1994;4:2016-2022.
88. Bakris G, White D: Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy. J Human Hyperten 1997;11:35-38.
89. Allgren RL, Marbury TC, Rahman SN, Weisherg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BRC, Conger JD, Sayegh MH: Anaritide in acute tubular necrosis. N Engl J Med 1997;336:828-834.